MTOR and COVID-19: Since insulin and glucose signalling positively regulate mTOR activity in the liver,114, 115 constitutive mTOR over‐activation in obese and diabetic patients116, 117, 118 could at least in part explain their higher risk for worse outcome of COVID‐19 (Figure 2).